Published in Drug Week, January 7th, 2005
The study was conducted by researchers at the Brain Tumor Center at the Duke Comprehensive Cancer Center and funded by the National Institutes of Health. Glioma is a devastating brain cancer that typically results in death in about a year.
Patients have few treatment options and nearly all available therapies have had minimal impact on survival. John Sampson, MD, PhD, associate professor of Neurosurgery at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week